€57.80
0.00% today
Xetra, Feb 05, 04:14 pm CET
ISIN
DE0005313704
Symbol
AFX
Index
Sector

Carl Zeiss Meditec Stock price

€57.80
+10.26 21.58% 1M
-3.10 5.09% 6M
+12.28 26.98% YTD
-43.00 42.66% 1Y
-78.80 57.69% 3Y
-57.20 49.74% 5Y
+33.94 142.25% 10Y
Xetra, Closing price Tue, Feb 04 2025
+0.05 0.09%
ISIN
DE0005313704
Symbol
AFX
Index
Sector

Key metrics

Market capitalization €5.06b
Enterprise Value €5.68b
P/E (TTM) P/E ratio 28.73
EV/FCF (TTM) EV/FCF 35.41
EV/Sales (TTM) EV/Sales 2.75
P/S ratio (TTM) P/S ratio 2.45
P/B ratio (TTM) P/B ratio 2.48
Dividend yield 1.04%
Last dividend (FY24) €0.60
Revenue growth (TTM) Revenue growth -1.11%
Revenue (TTM) Revenue €2.07b
EBIT (operating result TTM) EBIT €230.73m
Free Cash Flow (TTM) Free Cash Flow €160.51m
EPS (TTM) EPS €2.01
P/E forward 33.28
P/S forward 2.31
EV/Sales forward 2.59
Show more

Is Carl Zeiss Meditec a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,821 stocks worldwide.

Carl Zeiss Meditec Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a Carl Zeiss Meditec forecast:

6x Buy
35%
9x Hold
53%
2x Sell
12%

Analyst Opinions

17 Analysts have issued a Carl Zeiss Meditec forecast:

Buy
35%
Hold
53%
Sell
12%

Financial data from Carl Zeiss Meditec

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Sep '24
+/-
%
2,066 2,066
1% 1%
100%
- Direct Costs 978 978
11% 11%
47%
1,089 1,089
10% 10%
53%
- Selling and Administrative Expenses 382 382
11% 11%
18%
- Research and Development Expense 343 343
2% 2%
17%
364 364
15% 15%
18%
- Depreciation and Amortization 133 133
79% 79%
6%
EBIT (Operating Income) EBIT 231 231
35% 35%
11%
Net Profit 179 179
38% 38%
9%

In millions EUR.

Don't miss a Thing! We will send you all news about Carl Zeiss Meditec directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Carl Zeiss Meditec Stock News

AD HOC NEWS
8 days ago
Etwas mehr Zuversicht der US-Bank Goldman Sachs über die künftige Geschäftsentwicklung von Carl Zeiss Meditec DE0005313704 hat am Mittwoch die jüngst gestartete Erholung der Aktie des Medizintechnik-Unternehmens weiter vorangetrieben.Gegen Mittag legte das Papier um rund zwei Prozent auf 58,20 Euro zu und baute seine starken Kursgewinne seit Mitte Januar aus.
AD HOC NEWS
8 days ago
Die US-Investmentbank Goldman Sachs hat Carl Zeiss Meditec DE0005313704 von "Sell" auf "Neutral" hochgestuft und das Kursziel von 50 auf 60 Euro angehoben.
More Carl Zeiss Meditec News

Company Profile

Carl Zeiss Meditec AG engages in the development, manufacture, and marketing of medical devices. It operates through the Ophthalmic Devices and Microsurgery business segments. The Ophthalmic Devices segment includes intraocular lenses, surgical visualization solutions, and medical laser and diagnostic systems. The Microsurgery segment offers surgical microscopes and visualization solutions for neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiotherapy. The company was founded on October 4, 1995 and is headquartered in Jena, Germany.

Head office Germany
CEO Markus Weber
Employees 5,730
Founded 1995
Website www.zeiss.de

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today